Dow Up 0.07% Nasdaq Up 0.61%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
53.70 Down 0.29(0.54%) Nov 26, 4:00PM EST
|After Hours : 53.70 0.00 (0.00%) Nov 26, 4:36PM EST
Prev Close:53.99
Open:53.83
Bid:N/A
Ask:64.00 x 100
1y Target Est:87.50
Beta:2.04
Earnings Date:Feb 9 - Feb 13 (Est.)
Day's Range:53.40 - 54.48
52wk Range:41.99 - 80.42
Volume:220,137
Avg Vol (3m):385,666
Market Cap:1.08B
P/E (ttm):162.73
EPS (ttm):0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
LGNDDown 0.54%1.08B
LLYUp 0.70%72.01B
MRKUp 0.69%170.34B
RHHBYUp 0.54%254.20B

Key Statistics

Forward P/E (1 yr):22.95
P/S (ttm):19.21
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.53
Quarterly EPS Est (Dec-14) :0.61
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):1.18

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback